Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Irritable Bowel Syndrome (IBS) Health Center

Font Size

FDA Rejects New Drug for Irritable Bowel Syndrome


Last November, the FDA forced the IBS drug Lotronex to be taken off the market. Lotronex, which was made by Glaxo Wellcome, appeared to be a promising treatment for IBS when it was approved in February, 2000, but the FDA decided to remove it from the market after receiving complaints of serious gastrointestinal problems, including five deaths, possibly associated with the drug.

Novartis feels that the FDA may be taking a cautious approach to Zelnorm because of Lotronex, Pozarek says. Public Citizen's Health Research Group, a consumer advocacy organization, could be another factor. In March, the watchdog group filed a petition with the FDA claiming that Zelnorm increases a woman's risk for developing ovarian cysts. The drugmaker disagrees and says Public Citizen's concerns were based on incomplete information.

At a meeting last year, the FDA's own gastrointestinal drugs advisory committee said Zelnorm was effective and "did not voice any safety concerns," the agency's Jason Brodsky tells WebMD.

In addition, the FDA issued an "approvable" letter to Novartis in August, which stated that the drug could be approved, provided the company conducted one additional trial to confirm that the drug was safe and effective. Novartis conducted this trial and thought it had satisfied the FDA's concerns, Pozarek says.

"It is unusual" for the FDA not to follow the recommendation of its advisory committees, which consist of independent experts, Brodsky says, but he declined to offer further insight on why the FDA rejected Zelnorm.

Pozarek says Novartis has not decided if it will appeal the FDA's decision.

1 | 2

Today on WebMD

filling glass of water from faucet
Prevention strategies to try.
stomach ache
From symptoms to treatments.
Causes, symptoms, and treatments.
worried mature woman
Are they related?
IBS Trigger Foods
Supplements for IBS What Works
IBS Symptoms Quiz
digestive health
gluten free diet
digestive myths
what causes diarrhea
top foods for probiotics